Concepts (159)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Hand Hygiene | 6 | 2023 | 10 | 2.200 |
Why?
|
| Infection Control | 5 | 2023 | 115 | 1.590 |
Why?
|
| Guideline Adherence | 3 | 2021 | 223 | 1.190 |
Why?
|
| Infectious Disease Transmission, Professional-to-Patient | 2 | 2016 | 4 | 1.180 |
Why?
|
| Attitude of Health Personnel | 5 | 2021 | 636 | 1.010 |
Why?
|
| Anaphylaxis | 1 | 2023 | 33 | 0.910 |
Why?
|
| Cross Infection | 5 | 2023 | 141 | 0.870 |
Why?
|
| Disease Outbreaks | 3 | 2021 | 154 | 0.750 |
Why?
|
| Communicable Diseases | 2 | 2023 | 63 | 0.730 |
Why?
|
| Simulation Training | 1 | 2019 | 88 | 0.640 |
Why?
|
| Hand Disinfection | 2 | 2021 | 17 | 0.620 |
Why?
|
| Sorbitol | 1 | 2016 | 6 | 0.560 |
Why?
|
| Drug Utilization | 1 | 2016 | 65 | 0.560 |
Why?
|
| Foodborne Diseases | 1 | 2016 | 8 | 0.560 |
Why?
|
| Health Personnel | 4 | 2021 | 202 | 0.530 |
Why?
|
| Social Media | 1 | 2016 | 79 | 0.510 |
Why?
|
| Gastrointestinal Diseases | 1 | 2016 | 146 | 0.500 |
Why?
|
| Human Activities | 1 | 2013 | 7 | 0.480 |
Why?
|
| Epidemiological Monitoring | 1 | 2013 | 39 | 0.470 |
Why?
|
| Telemetry | 1 | 2013 | 38 | 0.470 |
Why?
|
| Education, Medical | 1 | 2016 | 233 | 0.470 |
Why?
|
| Clostridium Infections | 3 | 2023 | 125 | 0.460 |
Why?
|
| Health Knowledge, Attitudes, Practice | 2 | 2016 | 508 | 0.440 |
Why?
|
| Anti-Bacterial Agents | 2 | 2023 | 746 | 0.440 |
Why?
|
| Influenza, Human | 3 | 2018 | 329 | 0.320 |
Why?
|
| Influenza Vaccines | 2 | 2018 | 142 | 0.270 |
Why?
|
| Humans | 27 | 2023 | 86601 | 0.260 |
Why?
|
| Hospitals | 3 | 2023 | 294 | 0.220 |
Why?
|
| Emergency Service, Hospital | 2 | 2023 | 484 | 0.190 |
Why?
|
| Universities | 1 | 2021 | 135 | 0.190 |
Why?
|
| Students | 1 | 2021 | 147 | 0.180 |
Why?
|
| Patient Transfer | 1 | 2020 | 91 | 0.180 |
Why?
|
| Warts | 1 | 2019 | 11 | 0.170 |
Why?
|
| Heterocyclic Compounds | 1 | 2019 | 17 | 0.170 |
Why?
|
| Immunologic Deficiency Syndromes | 1 | 2019 | 47 | 0.170 |
Why?
|
| Academic Medical Centers | 3 | 2020 | 379 | 0.170 |
Why?
|
| Interprofessional Relations | 1 | 2019 | 121 | 0.170 |
Why?
|
| Receptors, CXCR4 | 1 | 2019 | 44 | 0.170 |
Why?
|
| Immunogenicity, Vaccine | 1 | 2018 | 13 | 0.170 |
Why?
|
| Chicago | 3 | 2021 | 1379 | 0.170 |
Why?
|
| Influenza A Virus, H3N2 Subtype | 1 | 2018 | 80 | 0.160 |
Why?
|
| Patient Care Team | 1 | 2019 | 280 | 0.150 |
Why?
|
| Bone Marrow | 1 | 2019 | 435 | 0.150 |
Why?
|
| Drug Resistance, Microbial | 1 | 2016 | 72 | 0.150 |
Why?
|
| Candida | 1 | 2016 | 17 | 0.150 |
Why?
|
| Culture Techniques | 1 | 2016 | 91 | 0.140 |
Why?
|
| Candidiasis | 1 | 2016 | 36 | 0.140 |
Why?
|
| Disinfection | 1 | 2016 | 14 | 0.140 |
Why?
|
| Equipment Contamination | 1 | 2016 | 22 | 0.140 |
Why?
|
| Organ Transplantation | 1 | 2020 | 265 | 0.140 |
Why?
|
| Technology | 1 | 2016 | 29 | 0.140 |
Why?
|
| Food Service, Hospital | 1 | 2016 | 4 | 0.140 |
Why?
|
| Hospitals, University | 1 | 2016 | 194 | 0.140 |
Why?
|
| Endosonography | 1 | 2016 | 96 | 0.140 |
Why?
|
| Civil Defense | 1 | 2015 | 11 | 0.130 |
Why?
|
| Hemorrhagic Fever, Ebola | 1 | 2015 | 11 | 0.130 |
Why?
|
| Epidemiologic Methods | 1 | 2015 | 59 | 0.130 |
Why?
|
| Fungi | 1 | 2015 | 65 | 0.130 |
Why?
|
| Pneumonia, Viral | 1 | 2020 | 316 | 0.130 |
Why?
|
| Coronavirus Infections | 1 | 2020 | 301 | 0.130 |
Why?
|
| Anti-Infective Agents | 1 | 2015 | 89 | 0.130 |
Why?
|
| Cystectomy | 1 | 2015 | 101 | 0.130 |
Why?
|
| Radio Frequency Identification Device | 1 | 2013 | 3 | 0.120 |
Why?
|
| Organothiophosphorus Compounds | 1 | 2013 | 17 | 0.120 |
Why?
|
| Public Health | 1 | 2015 | 129 | 0.120 |
Why?
|
| Clinical Competence | 1 | 2019 | 751 | 0.120 |
Why?
|
| Surgical Wound Infection | 1 | 2015 | 184 | 0.120 |
Why?
|
| Bacteria | 1 | 2017 | 447 | 0.120 |
Why?
|
| Intention | 1 | 2013 | 51 | 0.110 |
Why?
|
| Research Design | 1 | 2016 | 594 | 0.110 |
Why?
|
| Registries | 1 | 2016 | 702 | 0.110 |
Why?
|
| Sensitivity and Specificity | 1 | 2016 | 1990 | 0.110 |
Why?
|
| Predictive Value of Tests | 1 | 2016 | 1673 | 0.100 |
Why?
|
| Urinary Bladder Neoplasms | 1 | 2015 | 382 | 0.100 |
Why?
|
| Surveys and Questionnaires | 2 | 2016 | 2501 | 0.100 |
Why?
|
| Influenza A Virus, H1N1 Subtype | 1 | 2011 | 102 | 0.100 |
Why?
|
| Pandemics | 3 | 2023 | 740 | 0.080 |
Why?
|
| Delivery of Health Care | 2 | 2023 | 426 | 0.080 |
Why?
|
| Students, Medical | 1 | 2013 | 384 | 0.080 |
Why?
|
| Fatal Outcome | 2 | 2019 | 293 | 0.070 |
Why?
|
| Postoperative Complications | 1 | 2015 | 2207 | 0.070 |
Why?
|
| United States | 3 | 2023 | 6665 | 0.060 |
Why?
|
| Internship and Residency | 1 | 2013 | 1004 | 0.060 |
Why?
|
| Prevalence | 2 | 2020 | 1239 | 0.060 |
Why?
|
| Communicable Disease Control | 1 | 2023 | 51 | 0.060 |
Why?
|
| Travel-Related Illness | 1 | 2021 | 2 | 0.050 |
Why?
|
| Personnel, Hospital | 1 | 2021 | 30 | 0.050 |
Why?
|
| Retrospective Studies | 3 | 2023 | 8475 | 0.050 |
Why?
|
| Young Adult | 3 | 2021 | 5974 | 0.050 |
Why?
|
| Clinical Laboratory Techniques | 1 | 2020 | 73 | 0.050 |
Why?
|
| Medical Overuse | 1 | 2020 | 36 | 0.050 |
Why?
|
| Critical Illness | 1 | 2023 | 294 | 0.050 |
Why?
|
| Skilled Nursing Facilities | 1 | 2020 | 41 | 0.050 |
Why?
|
| Male | 6 | 2021 | 40956 | 0.040 |
Why?
|
| Benzylamines | 1 | 2019 | 16 | 0.040 |
Why?
|
| Neoplasms, Squamous Cell | 1 | 2019 | 19 | 0.040 |
Why?
|
| Risk Factors | 2 | 2023 | 5416 | 0.040 |
Why?
|
| Transplant Recipients | 1 | 2020 | 122 | 0.040 |
Why?
|
| Bone Marrow Examination | 1 | 2019 | 48 | 0.040 |
Why?
|
| Eggs | 1 | 2018 | 12 | 0.040 |
Why?
|
| Primary Myelofibrosis | 1 | 2019 | 56 | 0.040 |
Why?
|
| Dementia | 1 | 2020 | 187 | 0.040 |
Why?
|
| Ferrets | 1 | 2018 | 47 | 0.040 |
Why?
|
| Cross Reactions | 1 | 2018 | 106 | 0.040 |
Why?
|
| Genome, Viral | 1 | 2018 | 74 | 0.040 |
Why?
|
| Adult | 4 | 2023 | 25640 | 0.040 |
Why?
|
| Antigens, Viral | 1 | 2018 | 143 | 0.040 |
Why?
|
| Aged | 4 | 2018 | 18402 | 0.040 |
Why?
|
| Propionibacterium | 1 | 2017 | 6 | 0.040 |
Why?
|
| Staphylococcus | 1 | 2017 | 24 | 0.040 |
Why?
|
| Child | 2 | 2023 | 6926 | 0.040 |
Why?
|
| Inpatients | 1 | 2020 | 297 | 0.040 |
Why?
|
| Betacoronavirus | 1 | 2020 | 258 | 0.040 |
Why?
|
| Drug Resistance, Multiple, Fungal | 1 | 2016 | 3 | 0.040 |
Why?
|
| Seasons | 1 | 2018 | 223 | 0.040 |
Why?
|
| Communicable Diseases, Emerging | 1 | 2016 | 13 | 0.040 |
Why?
|
| Citrobacter freundii | 1 | 2016 | 2 | 0.040 |
Why?
|
| Hafnia alvei | 1 | 2016 | 2 | 0.040 |
Why?
|
| Klebsiella oxytoca | 1 | 2016 | 2 | 0.040 |
Why?
|
| Pseudomonas putida | 1 | 2016 | 5 | 0.040 |
Why?
|
| Sphingomonas | 1 | 2016 | 4 | 0.040 |
Why?
|
| Stenotrophomonas maltophilia | 1 | 2016 | 3 | 0.040 |
Why?
|
| Enterobacter cloacae | 1 | 2016 | 8 | 0.040 |
Why?
|
| Middle Aged | 4 | 2019 | 25017 | 0.040 |
Why?
|
| Acinetobacter baumannii | 1 | 2016 | 26 | 0.040 |
Why?
|
| Klebsiella pneumoniae | 1 | 2016 | 34 | 0.040 |
Why?
|
| Microbial Sensitivity Tests | 1 | 2016 | 143 | 0.030 |
Why?
|
| Aged, 80 and over | 2 | 2018 | 6501 | 0.030 |
Why?
|
| Antifungal Agents | 1 | 2016 | 117 | 0.030 |
Why?
|
| Adaptation, Physiological | 1 | 2018 | 306 | 0.030 |
Why?
|
| Female | 5 | 2021 | 44507 | 0.030 |
Why?
|
| Bayes Theorem | 1 | 2017 | 361 | 0.030 |
Why?
|
| Global Health | 1 | 2016 | 193 | 0.030 |
Why?
|
| Nasopharynx | 1 | 2015 | 47 | 0.030 |
Why?
|
| High-Throughput Nucleotide Sequencing | 1 | 2018 | 456 | 0.030 |
Why?
|
| Pseudomonas aeruginosa | 1 | 2016 | 194 | 0.030 |
Why?
|
| Viruses | 1 | 2015 | 78 | 0.030 |
Why?
|
| China | 1 | 2015 | 228 | 0.030 |
Why?
|
| Phylogeny | 1 | 2018 | 1137 | 0.030 |
Why?
|
| Polymerase Chain Reaction | 1 | 2015 | 927 | 0.030 |
Why?
|
| Phenotype | 1 | 2019 | 2377 | 0.030 |
Why?
|
| Microbiota | 1 | 2017 | 381 | 0.030 |
Why?
|
| Cohort Studies | 1 | 2018 | 2767 | 0.030 |
Why?
|
| Age Distribution | 1 | 2011 | 204 | 0.020 |
Why?
|
| Real-Time Polymerase Chain Reaction | 1 | 2011 | 273 | 0.020 |
Why?
|
| Neoplasm Staging | 1 | 2015 | 1937 | 0.020 |
Why?
|
| Illinois | 1 | 2011 | 462 | 0.020 |
Why?
|
| Follow-Up Studies | 1 | 2015 | 3636 | 0.020 |
Why?
|
| Electronic Health Records | 1 | 2011 | 319 | 0.020 |
Why?
|
| Prognosis | 1 | 2015 | 3674 | 0.020 |
Why?
|
| Prospective Studies | 1 | 2016 | 4210 | 0.020 |
Why?
|
| Logistic Models | 1 | 2011 | 1185 | 0.020 |
Why?
|
| Antiviral Agents | 1 | 2011 | 510 | 0.020 |
Why?
|
| Mutation | 1 | 2018 | 3967 | 0.020 |
Why?
|
| Infant, Newborn | 1 | 2011 | 2378 | 0.020 |
Why?
|
| Infant | 1 | 2011 | 3045 | 0.020 |
Why?
|
| Child, Preschool | 1 | 2011 | 3611 | 0.020 |
Why?
|
| Animals | 1 | 2018 | 26581 | 0.010 |
Why?
|
| Adolescent | 1 | 2011 | 8979 | 0.010 |
Why?
|